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Abstract: Cellular processes are influenced in many ways by changes in gravitational force. In
previous studies, we were able to demonstrate, in various cellular systems and research platforms
that reactions and adaptation processes occur very rapidly after the onset of altered gravity. In this
study we systematically compared differentially expressed gene transcript clusters (TCs) in human
Jurkat T cells in microgravity provided by a suborbital ballistic rocket with vector-averaged gravity
(vag) provided by a 2D clinostat. Additionally, we included 9× g centrifuge experiments and rigorous
controls for excluding other factors of influence than gravity. We found that 11 TCs were significantly
altered in 5 min of flight-induced and vector-averaged gravity. Among the annotated clusters were
G3BP1, KPNB1, NUDT3, SFT2D2, and POMK. Our results revealed that less than 1% of all examined
TCs show the same response in vag and flight-induced microgravity, while 38% of differentially
regulated TCs identified during the hypergravity phase of the suborbital ballistic rocket flight could
be verified with a 9× g ground centrifuge. In the 2D clinostat system, doing one full rotation per
second, vector effects of the gravitational force are only nullified if the sensing mechanism requires 1
s or longer. Due to the fact that vag with an integration period of 1 s was not able to reproduce the
results obtained in flight-induced microgravity, we conclude that the initial trigger of gene expression
response to microgravity requires less than 1 s reaction time. Additionally, we discovered extensive
gene expression differences caused by simple handling of the cell suspension in control experiments,
which underlines the need for rigorous standardization regarding mechanical forces during cell
culture experiments in general.
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1. Introduction
Earth’s gravitational force has been a constant condition during Earth’s history and the evolution
of cells and organisms [1]. The human organism reacts and partially adapts to altered gravity [2,3]
in a time frame of a few hours up to several weeks [4]. The cellular response to microgravity, such
as functional alterations [5,6], nucleus size, and shape [7–9], and RNA transcription [10,11] mostly
occurs within seconds, sometimes months [12–15]. The question about the mechanism by which
gravitational force is transmitted into a biological process was raised decades ago [16,17], but it
was rarely addressed in experimental approaches. For the “sensing” of gravity in eukaryotes [18],
cytoskeletal processes and mechanosensitive ion channels have been discussed, but the presented
theories remained speculative and were not substantiated by systematic experiments. Therefore,
none of the hypotheses of gravitational force sensing and transduction into a biological process in
mammalian cells has been confirmed by experimental data so far.
Gravitational force (FG) is one of the four fundamental physical forces in nature, has an attracting
character, and correlates linearly with an object’s mass. Newton’s law of gravity describes FG as the
product of two objects’ masses (m1, m2) attracting each other, divided by the square of the distance
(r), and scaled by the gravitational constant (G): FG = G(m1m2/r2). To calculate the gravitational force
exerted on an object on Earth, this formula can be simplified by setting the distance between the center
of the Earth and the object equal to the Earth’s radius (R⊕) and by combining G, Earth’s mass (M⊕), and
R⊕ into the gravitational acceleration constant g = 9.81 m/s2, yielding FG = mg. As described by Einstein
in his work on general relativity, there is no difference between the observation of a mass falling down in
a steady reference system (related to as gravitational mass) and a resting mass in a reference system that
is linearly accelerated towards the mass (related to as inertia mass). As consequence, the gravitational
force exerted on an object is only measurable if the reference system is not accelerated in the same way,
as for instance the International Space Station (ISS) in low Earth orbit. The ISS’s actual gravitational
acceleration, g, that would be measurable if it was not accelerated, is only reduced by 8% due to the
slightly greater distance to the Earth’s center [17], yet objects inside experience weightlessness relative
to the station. As a sum of many effects, every platform that supplies weightlessness has a residual
gravitational force, usually between 10−3 and 10−6 g [19,20]. The residual gravitational force can be
due to vibrations caused by on-board machinery, atmospheric drag, solar radiation pressure, and
gravitational attraction between the test object and the platform [21]. Depending on the mechanism
that is studied, different quality levels of microgravity are required. If a platform supplies microgravity
at a value below the mechanism’s threshold, it is also called functional weightlessness [22].
In weightlessness, hydrostatic pressure (as a result of weight of the water column on top of a
reference point) and sedimentation of particles in a solution (as a result of gravitational force and
buoyancy minus Stokes’ friction) are absent. Entropy-driven diffusion of particles resulting from
temperature dependent Brownian motion is present, whereas concentration dependent (Raleigh)
convection as a cause of buoyancy is absent. Therefore, mixing of liquids is affected by altered
gravity [17].
All these changes occur in altered gravity environment and have the potential to affect biological
processes. Due to the restriction of microgravity flight platforms, ground based facilities (GBFs) have
been developed to simulate microgravity conditions in biological experiments [20].
Since all GBFs are ground based, none of them is able to provide true force-free conditions.
By averaging forces, those devices attempt to simulate microgravity. Due to the logistical and cost
advantages, the popularity of GBFs is high, although the validity of GBFs in terms of producing
results comparable to flight-induced microgravity platforms remains uncertain. Clinostats rely on
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the principle of constantly turning a sample, thereby averaging out the gravitational force vector
around one (1D/2D clinostat) or two (3D clinostat) axes. Technically speaking, the gravitational
force still acts on the sample, but the direction of the gravitational vector on the sample is changing
constantly. This is why the terminology "vector-averaged gravity" (vag) is usually preferred over
"simulated microgravity” [23]. Whether the achieved results of a system compare to its behavior in
microgravity depends on the particular effect of interest [24]. The first 2D clinostats were used to
study plant gravitropism [25], in which a rotation speed of several seconds per revolution is sufficient
to simulate force-free conditions [26]. In general, rotation induces centrifugal forces that act like
additional gravitational forces and depend on the radius. Thus, fast rotating clinostats for cell culture
experiments have a very small diameter that minimizes the distance from the center to the sample,
usually in the range of millimeters [20]. Nevertheless, in addition to the centrifugal forces, Coriolis
force is also acting [22]. Further, 3D clinostats are a more recent development whereby the system
can independently rotate around a second axis, therefore allowing access to all three dimensions.
This allows averaging forces in all directions, potentially further decreasing effects of gravitational
sensing [27]. Random positioning machines (RPMs) are 3D clinostats that randomly change rotation
speed and direction, which is supposed to further randomize the gravity vector possibly beneficial for
averaging out gravitational effects [28,29]. However, the random movement changes seem to induce
shear stress into samples [30]. Rotating wall vessels (RWVs) are devices with liquids in horizontal
rotation where the speed is tuned to match the sedimentation speed of the contained objects, for example
cells [31]. As consequence, cells experience a constant mode of falling downwards (sedimentation)
with shear forces induced by the friction between the liquid and the objects [32]. Since sedimentation
is limited by this friction, cells still experience a (reduced) gravitational force. Because an averaging
of orientation may not be achieved for particles with anisotropic mass distribution, RWVs are only
suitable for certain types of applications, but not for achieving vag in cellular liquid cultures. The
stable levitation of diamagnetic samples like aqueous samples, and therefore most biological materials,
allows true microgravity simulation, since the gravitational force is compensated for by generating a
counteracting force in every point of an object and not only on the surface like for example in an RWV,
preventing any internal force [33]. However, the required strong magnetic fields of several Tesla are
likely to heavily influence cellular processes [34]. The wide use of clinostat microgravity simulators is
based on the assumption that most biological processes have longer integration times than the period
of gravitational vector rotation (e.g., 1 s for 60 rpm 2D clinorotation). The faster the studied mechanism
acts, the higher the rotation frequency must be set to guarantee conditions in which the gravitational
force vector is evenly distributed in all directions. Since the discovery of ultrafast reactions to altered
gravity, there is debate on the effectiveness of this approach [35].
Several mechanisms induced in microgravity are also sensitive to hypergravity [3,4]. Fixed-angle
centrifuges are well established and affordable platforms to generate hypergravity and 1× g control
conditions in microgravity experiments [36]. The underlying physical principle is that objects on
a circular trajectory experience centrifugal (pseudo-)force (because the rotating frame of reference
is no physical inertial frame). This force (FZ f) is dependent on the rotation angular frequency (ω
= 2pi f ), the radius (r) from the center, and the object’s mass (m): FZ f = mω2r = m 2pi f r. With
known dimensions of the centrifuge the (simulated) gravitational force can be tuned by varying the
rotation frequency. Centrifuge setups with adherent cells are prone to shear forces, if the geometry of
the vessel where cells are rotated in does not match the rotation circle (for example for flat bottom
vessels) [17,37]. Additionally, during centrifugation, Coriolis force occurs: If an object moves linearly
in an axis perpendicular to the rotating axis, the reference system (test tube/dish) moves a bit further.
From the rotating reference system’s point of view, moving objects therefore exhibit a curved trajectory.
The force is defined
→
FC = −2m(→ω ×→v ) with m being the object’s mass, ω = 2pi f being the centrifuge’s
rotation angular frequency and v being the object’s speed. In a liquid, molecules and particles move
around freely which is described by Brownian motion and therefore being influenced by the Coriolis
force. As a consequence, particles diffuse much slower during ultracentrifugation and show an elliptic
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and no more ball-shaped diffusion pattern [38]. This effect is smaller by many orders of magnitude
for slow rotation, e.g., when simulating slightly elevated gravitation levels, but could play a role for
biological macromolecules, during cellular signaling. Therefore, centrifuges are not an ideal simulation
of hypergravity. However, compared to ground based “simulators” for microgravity, this platform is
much closer to the real conditions.
Although several types of cultured cells are sensitive to gravity [39,40], the immune system belongs
to the most affected systems during spaceflight (reviewed in [41–43]). Sensitivity of human immune
cells to reduced gravity has been confirmed in numerous studies in flight-induced and simulated
microgravity (reviewed in [11,43]). Immune system weakening during long-term space flights could
contribute to an increased susceptibility to infections, autoimmunity, and cancer during exploration
class missions. Thus, it is indispensable to understand the cellular and molecular mechanisms by which
altered gravity changes genomic stability and gene regulation in cells of the immune system and to
assess mechanisms for adaptation. Changes of the gravitational environment induce strong alterations
of human physiological systems, which respond and adapt within hours and weeks [44]. At the
cellular level, changes of the gravitational force affect morphology, proliferation, differentiation, signal
transduction, and gene expression [45] and have been detected within seconds in isolated cells of the
immune system [10,12,13,46,47]. We recently investigated the dynamics of gene expression response to
different gravitational environments in human Jurkat T lymphocytes in combination of parabolic flights
with a suborbital ballistic rocket experiment and with control experiments for excluding all possible
other factors of influence [13,14]. In these experiments, we detected a significantly high number of
differentially regulated transcripts after 20 s of microgravity exposure [13], and gene clusters which are
stable in different gravity environments [14]. According a recent comparison, the biological responses of
cells in suspension in a 2D clinostat is similar to those in flight-induced microgravity [20]. We therefore
aimed to validate this current state of the art opinion by systematically comparing transcriptomics
data from human Jurkat T cells in microgravity provided by a suborbital ballistic rocket mission with
vag provided by a 2D clinostat and hypergravity provided by 9× g centrifuge experiments. Thus, we
performed ground based studies in a 2D clinostat and a hypergravity centrifuge using comparable
experimental conditions to the parabolic flight and suborbital ballistic rocket experiments. Our aim
was also to investigate if the underlying mechanisms for the perception and transduction of the
gravitational force into chromatin is faster or slower than the time needed in a 2D clinostat to average
gravitational force in all directions once, meaning one revolution per second. If the transcriptome effect
of flight-induced microgravity can be reproduced in a 2D clinostat, the process of primary gravity
perception must take longer than 1 s.
2. Results
2.1. 2D Clinostat, Centrifuge and Suborbital Ballistic Rocket Experiments with Human Jurkat T Cells
GBFs, like 2D clinostats and centrifuges, are commonly used platforms for pre-testing and
verification of real microgravity (µg) and hypergravity (hyp-g) experiments. Due to the ballistic flight
trajectory, it is an inherent limitation of the parabolic flight and suborbital ballistic rocket microgravity
platforms that the launch and hypergravity phase is preceding the microgravity phase. The launch
phase of TEXUS-51 consisted of two phases: the first one (stage 1 motor) had a duration of 12.2 s
with a thrust acceleration of 5.1× g average and 8.1× g peak, and the second one (stage 2 motor) had
a duration of 28.2 s and a thrust acceleration of 6.7× g average and 12.6× g peak, with an additional
spin of 2.8 Hz. The pull-up-phase of the parabolic trajectory of the Airbus A310 ZERO consisted of
22s hypergravity up to 1.8× g. For this reason, we included different types of control experiments
(Figure 1).
During the suborbital rocket experiment TEXUS-51, the following cell samples were obtained: (1)
TX hyp-g: 75 s after launch, i.e. after the hypergravity phase and before the microgravity phase, (2) TX
µg: after 5 min of microgravity, (3) H/W 1× g GC: 1× g on ground in the experiment hardware under
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identical conditions as in the rocket except the gravitational force, (4) 1× g IF: 1× g in-flight during the 5
min microgravity phase using an on-board centrifuge, and (5) CC: under regular cell culture conditions
at 1× g to control the hardware effect (Table 1, Figures 1 and 2). In the case of the GBF experiments,
human Jurkat T cells were filled into sterile plastic pipettes with a diameter of approximately 3.5 mm,
sealed, and inserted in the clinostat and rotated at 60 rpm for 5 min at 37 ◦C. Hardware 1× g control
samples (1× g control) were prepared similarly and placed on the base plate of the clinostat to monitor
instrument effects such as vibrations. A further 1× g control (Baseline; BL) was prepared, in which
cells were aspirated into the pipette and immediately drained again to monitor potential effects based
on the pipetting procedure. GBF hypergravity experiments were performed by installing pipettes
filled with human Jurkat T cells in a centrifuge and rotated at 9× g for 5 min at 37 ◦C (Table 1, Figures 1
and 2). The chosen speed of 9× g was in the range of the acceleration of the TEXUS-51 suborbital
ballistic rocket (between 5.1× g for first stage mean thrust acceleration and 12.6× g for second stage
peak thrust acceleration). For both experiment platforms, total RNA from at least five samples was
processed for each group and hybridized on microarray chips.
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Figure 1. Experiment hardware used for (a) ground based facilities (GBFs) experiments and (b) 
experiments on board the suborbital ballistic rocket TEXUS-51. (a1 and a2): Fast rotating 2D clinostat 
for use with 1mL pipettes built by the German Aerospace Center (DLR). (a3 and a4): 9× g centrifuge 
for use with 1mL pipettes built by KEK GmbH, Bad Schmiedeberg, Germany. (a5): Sterile 1mL pipette 
(3.5 mm diameter) in which Jurkat T cells were filled and placed in the 2D clinostat or the 9× g 
centrifuge. (b1): For the suborbital ballistic rocket experiment Jurkat T cells, medium, and lysis buffer 
were filled in three syringes connected by a T piece. These assemblies were stacked in tempered and 
vacuum-tight containers (b2 and b3) which allow hydraulic impression of the syringe plungers 
ensuring mixture of the fluids at defined times during flight. Containers were installed either on the 
static (b5) or the centrifuge (b4) position of the in-flight experiment system. (b6) Assembled payload 
structures (red) and service module (white) of the TEXUS-51 rocket. Rocket motors are not shown. 
Figure 1. Experiment hardware used for (a) ground based facilities (GBFs) experiments and (b)
experiments on board the suborbital ballistic rocket TEXUS-51. (a1 and a2): Fast rotating 2D clinostat
for use with 1mL pipettes built by the German Aerospace Center (DLR). (a3 and a4): 9× g centrifuge for
use with 1mL pipettes built by KEK GmbH, Bad Schmiedeberg, Germany. (a5): Sterile 1mL pipette (3.5
mm diameter) in which Jurkat T cells were filled and placed in the 2D clinostat or the 9× g centrifuge.
(b1): For the suborbital ballistic rocket experiment Jurkat T cells, medium, and lysis buffer were filled
in three syringes connected by a T piece. These assemblies were stacked in tempered and vacuum-tight
containers (b2 and b3) which allow hydraulic impression of the syring plungers ensuring mixture
of the fluids at defin d times during flight. Containers w e ins alled either on the static (b5) or the
centrif ge (b4) position of the in-flight experiment system. (b6) Assembled payload structures (red)
and service module (white) of the TEXUS-51 rocket. Rocket motors are not shown.
Int. J. Mol. Sci. 2020, 21, 514 6 of 37I t. J. ol. Sci. 2020, 21, 514  f 9 
 
Figure 2. Sample lysis-scheme of ground based facilities (GBF) experiments and experiments on board a 
suborbital ballistic rocket flight. (a) During GBF experiments Jurkat T cells were exposed to 2D clinorotation 
or 9× g centrifugation. Including controls, four sample groups were included in the experiment: (1) 2D 
clinostat samples which were clinorotated for 300 s, (2) 9× g centrifuge samples which were centrifuged for 
300 s, (3) Baseline (BL) control samples were lysed after the cells had been filled into the pipettes to simulate 
the effects of the experiment preparation handling, and (4) Hardware 1× g control samples were incubated 
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Figure 2. Sample lysis-scheme of ground based facilities (GBF) experiments and experiments on board
a suborbital ballistic rocket flight. (a) During GBF experiments Jurkat T cells were exposed to 2D
clinorotation or 9× g centrifugation. Including controls, four sample groups were included in the
experiment: (1) 2D clinostat samples which were clinorotated for 300 s, (2) 9× g centrifuge samples
which were centrifuged for 300 s, (3) Baseline (BL) control samples were lysed after the cells had been
filled into the pipettes to simulate the effects of the experiment preparation handling, and (4) Hardware
1× g control samples were incubated at 1× g in parallel to the clinorotation and the centrifugation
samples. (b) During the DLR suborbital ballistic rocket flight campaign TEXUS-51 Jurkat T cells
were exposed to hypergravity and subsequently to microgravity, in total five sample groups were
produced including control groups: (1) Hypergravity (TX hyp-g) samples were lysed directly after the
hypergravity phase at T+75 s, (2) Microgravity (µg) samples were lysed after the 300 s microgravity
phase at T+375 s, (3) 1× g in-flight control (1× g IF) samples were installed on a 1× g centrifuge on
board the rocket and were lysed at the same time as the µg samples, (4) Hardware 1× g control (H/W
1× g GC) samples were subjected to an identical hardware on ground and were lysed about 15 min
after launch, and (5) Cell culture controls (CC) were kept under standard cell culture conditions (37 ◦C
and 5% CO2 in an incubator) and lysed in parallel to the H/W 1× g GC samples.
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Table 1. Gravity conditions and controls of experimental groups of the ground based facilities experiments (GBF) and the TEXUS-51 suborbital ballistic rocket flight
campaign. Due to the ballistic trajectory, microgravity platforms such as parabolic flights and sounding rockets always contain a hypergravity phase preceding the
microgravity phase, limiting the experiments and requiring appropriate controls groups. Additional information on the group is given in brackets. GBF: ground based
facilities; TEXUS: German for “Technologische Experimente unter Schwerelosigkeit”; n/a: not available; CC: cell culture control; min: minute(s); H/W: hardware; g:


















Cell culture control n/a
CC
(cell culture control: cells kept under standard cell culture conditions
in a cell culture incubator)
Hardware 1× g ground control
1× g ground control [5 min]
(sample exposure inside the pipettes used for
centrifugation and 2D clinorotation
experiments)
H/W 1× g GC
(hardware 1× g ground control: ground control samples incubated in
the hardware identical in construction to the flight hardware for
identification of hardware-based effects)
1×gin-flight control n/a
1× g IF [5 min]
(1× g in flight: sample exposure to 75s hypergravity max. 12.6× g plus
5 min 1× g centrifugation in the centrifuge on board the suborbital
rocket during the flight)
Baseline control
BL
(filling and draining of pipettes for identification
of pipetting effects)
n/a
Hypergravity 9× g centrifuge [5 min](sample exposure to centrifugal forces of 9g)
TX hyp-g [75 s, max. 12.6× g]
(sample exposure to hypergravity with a maximum of 12.6× g during
the first 75 s of the rocket launch)
Vector-averaged gravity (vag)/Microgravity (µg) 2D clinostat [5 min](sample exposure to vector averaged gravity)
TX µg [5 min]
(sample exposure to 75 s, max. 12.6× g followed by 5 min microgravity
during the suborbital rocket flight)
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2.2. Identification of Differential Gene Expression in Ground Based Facilities Experiments
During 2D clinorotation for 5 min, 1141 TCs were differentially expressed, while during
centrifugation at 9× g for the same time period 5778 TCs, i.e., more than five-fold, were identified to be
differentially regulated. In the direct comparison of the two ground based facilities (2D clinostat vs. 9×
g centrifuge), 962 TCs were differentially expressed (Table 2, Figure 3a). After elimination of the control
comparison transcripts (1× g control vs. BL), in order to exclude hardware and vibration induced gene
expression differences, 871 TCs and 4596 TCs were identified to be differentially expressed during
clinorotation (2D clinostat vs. 1× g control) and 9× g centrifugation (9× g centrifuge vs. 1× g control),
respectively (Figure 3a, Table 3). Average fold change values for vector-averaged gravity sensitive TCs
(2D clinostat vs. 1× g control) were −1.38 and +1.39 with minimum and maximum values of −2.22 and
+ 2.38, respectively. Hypergravity sensitive TCs (9× g centrifuge vs. 1× g control) showed average
fold change numbers of −1.44 and +1.52 with minimum and maximum values of −4.00 and +4.28,
respectively. The direct comparison of 2D clinostat with 9× g centrifuge revealed 752 differentially
expressed TCs (after subtraction of control) with average fold change values of −1.40 and +1.41 with
minimum and maximum of −2.12 and +2.43, respectively (Table 3).
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Figure 3. Numbers of differ ntially expres script clusters (TCs) in comparis ns of different
gravitational conditions from ground based f ciliti s ( BFs) experiments. Differential xpression is
defined as p-value < 0.05; fold change ≤ −1.3 or ≥ 1.3. Numbers are differentially expressed TCs
considering all TCs on the Affymetrix GeneChip™Human Transcriptome Array 2.0, while the numbers
of differentially expressed annotated TCs are given in brackets. The Venn diagrams identify overlaps of
differentially expressed TCs in the different comparisons. (a) Application of control: Overlaps of the
comparisons of the three experimental conditions (outer circles) to the essential control comparison 1×
g control vs. BL identifying transcripts that are sensitive to the experiment procedure itself, regardless
Int. J. Mol. Sci. 2020, 21, 514 9 of 37
of the gravity condition. Consequently, the TCs in the overlaps are excluded from the sets of TCs of the
three experimental comparisons. The remaining sets of TCs in these experiment comparisons (colored)
are therefore referred to as “1× g control vs. BL-controlled” or abbreviated “controlled”. (b) Overlaps
of the controlled sets of TCs of the three comparisons. The Venn diagram identifies 222 (148) TCs that
are differentially expressed in all three comparisons (yellow).
Table 2. Numbers of differentially expressed transcript clusters (TCs) in comparisons of the experiment
groups of ground based facilities experiments (GBF). In total 67528 transcript clusters were analyzed
by the Affymetrix GeneChip™ Human Transcriptome Array 2.0 including 35219 annotated transcript
clusters. Differential expression is defined as p-value < 0.05; fold-change ≤ −1.3 or ≥1.3.
Significantly Differentially Expressed TCs in the GBF Experiments
1× g Control vs. BL 9× g Centrifuge vs.1× g Control
2D Clinostat vs. 1×
g Control




upregulated 2125 3046 768 339
downregulated 496 2732 373 623




upregulated 890 2089 475 149
downregulated 187 1238 155 355
total number 1077 3327 630 504
We further screened the data for double-sensitive transcripts in the comparisons 2D clinostat
versus 1× g control and 9× g centrifuge versus 1× g control and identified 798 differentially regulated
TCs. Hereof, 222 TCs were also differentially expressed in the comparison 2D clinostat versus 9×
g centrifuge (Figure 3b, Table 3). The respective average, minimum, and maximum fold change
expression values are shown in Table 3.
2.3. Comparison of GBFs with TEXUS-51 Gene Expression Results
The results of the GBFs experiments were compared to the results of the TEXUS-51 suborbital
rocket experiment in order to evaluate the validity of the GBFs in preliminary studies to test experiment
designs and pre-select experiment parameters for later suborbital rocket missions. For this purpose,
the flight-induced microgravity-sensitive (differentially expressed in the comparison TX µg versus TX
1× g IF) and hypergravity-sensitive (differentially expressed in the comparison TX hyp-g versus TX 1×
g IF) transcripts identified in the TEXUS-51 experiment were directly compared to the results from the
GBF study.
In total, 2128 TCs were flight-induced microgravity-sensitive and 2573 TCs were
hypergravity-sensitive in the TEXUS-51 study. In addition, 46 differentially expressed TCs could be
identified in the comparison TX µg versus TX hyp-g (Figure 4a, Table 4). After filtering out all TCs
that showed differential expression under control comparisons to avoid potential gravity-independent
false positive hits (i.e. comparisons: H/W 1× g GC vs. CC and 1× g IF vs. H/W 1× g GC), we
were able to identify 396 microgravity-sensitive (TX µg vs. 1× g IF), 346 hypergravity-sensitive (TX
hyp-g vs. 1× g IF) and 19 TCs expressed differentially in the comparison TX µg versus TX hyp-g
(Figure 4a, Table 5). Average fold change values for microgravity-sensitive TCs (TX µg vs. TX 1×
g IF) were −1.36 and +1.40 with minimum and maximum values of −1.83 and +1.85, respectively.
Hypergravity-sensitive TCs (TX hyp-g vs. 1× g IF) showed average fold change numbers of -1.36 and
+1.45 with minimum and maximum values of −1.92 and +1.94, respectively. The direct comparison
TX µg versus TX hyp-g revealed average fold change values of −1.39 and +1.37 with minimum and
maximum of −1.68 and +1.43, respectively (Table 5). The analysis of “double-sensitive” TCs that are
both microgravity-sensitive and hypergravity-sensitive (TX µg vs. 1× g IF and TX hyp-g vs. 1× g IF)
revealed 134 TC hits (Figure 4b, Table 5). The respective fold change values for average as well as for
minimum and maximum expression differences are displayed in Table 5. None of these identified
“double-sensitive” transcripts were differentially expressed in the TX µg versus TX hyp-g comparison
(Figure 4b).
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Table 3. Numbers of differentially up and downregulated transcript clusters (TCs) in response to exposure to 2D clinorotation and/or 9× g centrifugation. Transcript
clusters that were significantly changed in the control comparison 1× g control vs. BL were eliminated. Average fold change (FC), minimum and maximum values of
each comparison are shown. Differential expression is defined as p-value < 0.05; FC ≤ −1.3 or ≥ 1.3. ↑: upregulated TCs; ↓: downregulated TCs. * Refers to the
comparison that is mentioned first in the left column. # TCs are regulated in the same direction in 2D clinostat vs. 1× g control and 9× g centrifuge vs. 1× g control
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gravitational conditions from the DLR suborbital ballistic rocket flight campaign Texus-51. Differential
expression is defined as p-value <0.05; fold change ≤ −1.3 or ≥ 1.3. Numbers are differentially expressed
TCs considering all TCs on the Affymetrix GeneChip™ Human Transcriptome Array 2.0, while the
numbers of differentially expressed annotated TCs are given in brackets. The Venn diagrams identify
overlaps of differentially expressed TCs in the different comparisons. (a) Application of controls:
Overlaps of the comparisons of the three experimental conditions (outer circles) to the essential two
control comparisons H/W 1× g GC vs. CC and 1× g IF vs. H/W 1× g GC identifying transcripts that are
sensitive to the experiment procedure itself, regardless of the gravity condition. Consequently, the TCs
in the overlaps are excluded from the sets of TCs of the three experimental conditions. The remaining
sets of TCs in these experiment comparisons (colored) are therefore referred to as “comparisons H/W
1× g GC vs. CC and 1× g IF vs. H/W 1× g GC -controlled” or abbreviated “controlled”. (b) Overlaps
of the controlled sets of TCs of the three comparisons. The Venn diagram identifies zero TCs that
are differentially expressed in all three comparisons (yellow). However, several TCs are differentially
expressed in the intersections of two comparisons.
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Table 4. Numbers of differentially expressed transcript clusters (TCs) in comparisons of the experiment groups of the suborbital ballistic rocket experiment TEXUS-51.
In total 67528 transcript clusters were analyzed by the Affymetrix GeneChip™ Human Transcriptome Array 2.0 including 35219 annotated transcript clusters.
Differential expression is defined as p-value < 0.05; fold change ≤ −1.3 or ≥ 1.3.
Significantly Differentially Expressed TCs in the TEXUS-51 Experiments
H/W 1× g GC
vs. CC
1× g IF vs. H/W
1× g GC
TX hyp-g vs.
H/W 1× g GC
TX hyp-g vs.
1× g IF
TX µg vs. H/W
1× g GC
TX µg vs. 1× g
IF





upregulated 15,995 571 2874 1842 2295 1101 23
downregulated 7886 536 1144 731 1207 1027 23




upregulated 9243 258 2039 1270 1575 721 5
downregulated 4828 282 426 193 425 315 2
total number 14,071 540 2465 1463 2000 1036 7
Table 5. Numbers of differentially up and downregulated transcript clusters (TCs) in response to hypergravity and microgravity during the suborbital ballistic rocket
flight TEXUS-51. Transcript clusters that were significantly changed in the control comparisons H/W 1× g GC vs. CC and 1× g IF vs. H/W 1× g GC were eliminated.
Average fold change (FC), minimum and maximum values of each comparison are shown. Differential expression is defined as p-value < 0.05; FC ≤ −1.3 or ≥ 1.3. ↑:
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Figure 5 summarizes the number of differentially expressed TCs for the GBFs and the TEXUS-51
suborbital rocket mission and divides them into up and downregulated transcripts in the different
gravitational conditions. In general, in the ground based facilities clinostat and 9× g centrifuge, more
TCs are upregulated than downregulated. Interestingly, the exposure to 9× g centrifugation for 5 min
leads to a fivefold increase in differentially regulated transcripts compared to 5 min of 2D clinorotation.
Furthermore, in hypergravity as well as in vag more transcripts are upregulated than downregulated
(Figure 5a, Table 3). In contrast, the transcriptome analysis of the TEXUS-51 mission showed fewer
differentially regulated transcripts in hypergravity and in microgravity. Moreover, the clear trend that
more transcripts are differentially regulated in hypergravity than in microgravity cannot be observed
on this platform: the total numbers of differentially regulated transcripts differ only insignificantly
(396 microgravity-sensitive TCs and 346 hypergravity-sensitive TCs). Furthermore, in the dataset
of the TEXUS-51 mission, the downregulated transcripts predominate in hypergravity as well as in
microgravity (Figure 5b, Table 5).
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Figure 5. Numbers of transcript clusters (TCs) that are differentially expressed in response to
hypergravity or flight-induced microgravity/vector-averaged gravity (vag). The proportion of up
and downregulated TCs is shown. (a) Hypergravity and vag-sensitive TCs from ground based
facilities experiments. (b) Hypergravity and microgravity sensitive TCs from suborbital ballistic
rocket experiments.
Next, we performed a deeper analysis of the aforementioned “double-sensitive” TCs that react to
both, hypergravity and microgravity. In the case of the GBFs experiments, 798 TCs (476 annotated
TCs) could be identified which were differentially regulated in hypergravity and vag (Figure 6).
This corresponds to 17% of the total number of hypergravity-sensitive and 92% of the vag-sensitive
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transcripts. In the TEXUS-51 suborbital rocket experiment, we identified 134 TCs (42 annotated TCs)
as double-sensitive. This corresponds to 39% of the total number of the hypergravity-sensitive and
34% of the microgravity-sensitive transcripts (Figure 7). Interestingly, in the GBFs and the TEXUS-51
suborbital rocket experiment, every identified “double-sensitive” transcript was regulated consistently
between hypergravity versus 1× g and microgravity versus 1× g in terms of direction of fold change
(Figures 6 and 7).
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Figure 6. Hypergravity and vector-averaged gravity (vag) double-sensitive transcript clusters (TCs)
from ground based facilities (GBFs) experiments. (a) Venn diagram showing overlap of hypergravity
(comparison 9× g centrifuge vs. 1× g control) and vag (comparison 2D clinostat vs. 1× g control)
-sensitive TCs (yellow area). Numbers are differentially expressed TCs considering all TC on the
Affymetrix GeneChip™ Human Transcriptome Array 2.0. The numbers of differentially expressed
annotated TCs are given in brackets. All TCs in the overlap section are regulated in the same direction,
while none is regulated reversely. (b) Bar chart showing fold changes (FCs) of the 798 double sensitive
TCs. FCs are ratios of the averaged expression values (linear) of a TC from the experimental groups
that were compared. All TCs are regulated in the same direction in response to hypergravity and
vector-averaged gravity.
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2.4. GBFs and TEXUS-51 Cross Platform Comparison of Hypergravity and Microgravity-Sensitive TCs
A cross platfo m comparison should benchmark how comparable the results of the GBFs
experiments are with those of the TEXUS-51 suborbital flight. In case of the hypergravity-sensitive
transcripts, 42 TCs (28 annotated TCs belonging to 25 genes) were identified in both platforms (Figure 8,
Table 6). This represents 1% of the GBFs and 12% of the TEXUS-51 hypergravity-sensitive transcripts.
22 annotated TCs, i.e., 79% of these double-sensitive transcripts were regulated in the same direction,
while six TCs were regulated i the pposite directio . Functional annotation analysis of these 25 genes
identified significant enrichment in eight GeneOntology (GO) terms: transport, cyt sol, nucleotide
binding, poly(A) RNA binding, nuclear speck, RNA binding, intracellular membrane-bounded
organelle, and regulation of alternative mRNA splicing, via spliceosome, as listed in Table 7. We
also compared the intersection of vag (GBFs) and flight-induced microgravity (TEXUS-51)-sensitive
transcripts. In total, 11 TCs could be identified in the intersection. This represents 1% of the GBFs and
3% of the TEXUS-51 vag/flight-induced microgravity-s nsitive ranscripts. 82% (five annotated TCs)
of these double-positive transcripts were regulated in the same direction and none of the annotated
TCs was regulated reversely (Figure 9, Table 6). Finally, we compared the hyper- and microgravity
double sensitive TCs of the two platforms. Of the 798 TCs (GBFs) and 134 TCs (TEXUS-51), six TCs
(four annotated TCs) could be identified which were differentially expressed in both platforms and
regulated in the same direction. This represents 1% of the GBFs and 4% of the TEXUS-51 hypergravity
and vector-averaged gravity/flight-induced microgravity double-sensitive TCs (Figure 10, Table 6). The
functional GeneOntology based analyses revealed no significant enrichment of differentially expressed
transcripts in GO terms for microgravity-sensitive and hyper- and microgravity double-sensitive TCs
of the two platforms.
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Figure 8. Cross platform comparison of hypergravity-sensitive transcript clusters (TCs) from ground
based facilities (GBFs) and suborbital ballistic rocket experiments. (a) Venn diagram showing overlap
of hypergravity-sensitive TCs from GBF and from suborbital ballistic rocket experiments (yello area).
Numb rs are differentially expressed TC consideri g all TCs on the Affymetrix GeneChip™ Human
Transcriptome Array 2.0. The numbers of diffe entially expressed annotated TCs are given in brackets.
33 TCs in th overlap section are regulated in the s me direction, while 9 are regulated reversely. (b)
Bar chart showing fold changes (FCs) of the 42 TCs sensitive to hypergravity in both experimental
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groups that were compared.
Table 6. Differentially regulated transcript clusters identified for both, the ground based facilities
experiment and the suborbital ballistic rocket experiment TEXUS-51. Comparison of the different data
sets revealed 28 annotated hypergravity-sensitive transcript clusters, 5 annotated microgravity-sensitive
transcript clusters, and 4 hypergravity and vector-averaged gravity/flight-induced microgravity
double-sensitive annotated transcript clusters. Significant differential expression is defined as p-value
< 0.05; FC ≤ −1.3 or ≥ 1.3.
Ground Based Facilities Fold Changes TEXUS-51 Fold Changes
Gene Symbol Transcript Cluster ID 9× g Centrifuge vs.1× g Control




TX µg vs. 1× g
IF
Hypergravity-sensitive transcript clusters
ATP6V1A TC03000583.hg.1 1.57 1.34
BCAT1 TC12001309.hg.1 1.31 1.35
CAT TC11000327.hg.1 1.39 1.31
CBFB TC16000528.hg.1 1.60 1.42
CERS6 TC02000996.hg.1 1.37 1.42
EAF1 TC03000096.hg.1 1.39 1.30
ETS1 TC11002439.hg.1 1.55 1.38
G3BP1 TC05000844.hg.1 1.54 1.32
GAN TC16000638.hg.1 1.33 1.35
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Table 6. Cont.
Ground Based Facilities Fold Changes TEXUS-51 Fold Changes
Gene Symbol Transcript Cluster ID 9× g Centrifuge vs.1× g Control




TX µg vs. 1× g
IF
KPNB1 TC17000611.hg.1 1.93 1.61
NET1 TC10000047.hg.1 1.38 1.45
NUDT3 TC06004129.hg.1 1.68 1.39
PAG1 TC08001361.hg.1 1.32 1.30
PELI2 TC14000332.hg.1 1.43 1.36
POM121L9P TC05000487.hg.1 1.42 −1.36
POM121L9P TC05000309.hg.1 1.41 −1.31
POM121L9P TC05000321.hg.1 1.41 −1.31
POM121L9P TC06000218.hg.1 1.41 −1.31
POM121L9P TC06000691.hg.1 1.41 −1.31
PRPS1 TC0X000526.hg.1 1.37 1.31
RBM3 TC0X000255.hg.1 1.35 1.34
RBM8A TC01001093.hg.1 1.44 1.55
RSC1A1; DDI2 TC01000193.hg.1 1.44 1.32
SAMD9 TC07001605.hg.1 −1.34 1.35
SFT2D2 TC01006289.hg.1 1.72 1.34
SRP14 TC15001228.hg.1 1.42 1.41
SRSF6 TC20000316.hg.1 1.38 1.39
TMED8 TC14001343.hg.1 1.38 1.31
Vector-averaged gravity/flight-induced microgravity-sensitive transcript clusters
G3BP1 TC05000844.hg.1 1.30 1.30
KPNB1 TC17000611.hg.1 1.38 1.53
NUDT3 TC06004129.hg.1 1.36 1.45
POMK; SGK196 TC08000332.hg.1 1.43 1.32
SFT2D2 TC01006289.hg.1 1.39 1.36
Hypergravity and vector-averaged gravity/flight-induced microgravity double-sensitive transcript clusters
G3BP1 TC05000844.hg.1 1.54 1.30 1.32 1.30
KPNB1 TC17000611.hg.1 1.93 1.38 1.61 1.53
NUDT3 TC06004129.hg.1 1.68 1.36 1.39 1.45
SFT2D2 TC01006289.hg.1 1.72 1.39 1.34 1.36
Table 7. Functional annotation of the 28 identified annotated hypergravity-sensitive transcript clusters
(belonging to 25 genes) listed in Table 6. Eight significant gene ontology enrichments were found.
(Microgravity-sensitive transcript clusters and hypergravity and vector-averaged gravity/flight-induced
microgravity double-sensitive transcript clusters could not be assigned significantly to any functional
annotation).
Category Enriched Term Gene Count % of Genes ModifiedFisher p-Value
Fold
Enrichment
GOTERM_BP_DIRECT Transport 5 20 9.9 × 10−4 10.5
GOTERM_CC_DIRECT Cytosol 11 44 4.4 × 10−3 2.5
GOTERM_MF_DIRECT Nucleotide binding 4 16 8.8 × 10−3 8.8
GOTERM_MF_DIRECT Poly(A) RNA binding 6 24 1.1 × 10−2 4.1
GOTERM_CC_DIRECT Nuclear speck 3 12 2.6 × 10−2 11.3
GOTERM_MF_DIRECT RNA binding 4 16 1.9 × 10−2 5.6
GOTERM_CC_DIRECT Intracellularmembrane-bounded organelle 4 16 3.2 × 10−2 5.4
GOTERM_BP_DIRECT Regulation of alternative mRNAsplicing, via spliceosome 2 8 4.9 × 10−2 38.4
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values (linear) of a TC from the experimental groups that were compared. 
Figure 9. Cross platform comparison of vector-averaged gravity (vag) and flight-induced
microgravity-sensitive transcript clusters (TCs) from ground based facilities (GBFs) and suborbital
ballistic rocket experiments. (a) Venn diagram showing the overlap of the vag-sensitive TCs from
GBF with the microgravity-sensitive TCs from suborbital ballistic rocket experiments (yellow area).
Numbers are differentially expressed TCs considering all TC on the Affymetrix GeneChip™ Human
Transcriptome Array 2.0. The numbers of differentially expressed annotated TCs are given in brackets.
9 TCs in the overlap section are regulated in the same direction, while 2 are regulated in the opposite
direction. (b) Bar chart showing fold changes (FCs) of the 11 TCs sensitive to vag and flight-induced
microgravity in both experimental platforms. FCs are ratios of the averaged expression values (linear)
of a TC from the experimental groups that were compared.
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same direction in all gravity conditions from both experimental platforms. (b) Bar chart showing fold 
changes (FCs) of the 6 TCs in all 4 relevant comparisons. FCs are ratios of the averaged expression 
values (linear) of a TC from the compared experimental groups. All TCs are upregulated in the 4 
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flight-induced microgravity was additionally examined in minimally (Figure 11b) and non-
controlled comparisons (Figure 11c). While under maximum control conditions, 16 TCs differentially 
expressed in flight-induced microgravity and vag could be identified, while under minimally and 
non-controlled conditions, 271 and 431 TCs respectively emerged as being differentially expressed 
for both platforms. This means that, even under non-controlled conditions, only 12% of the 
differentially regulated TCs identified in flight-induced microgravity could be verified by the 
application of vag using a 2D clinostat. On the other hand, 38% of the 1141 differentially expressed 
TCs identified in vag show gene expression differences in flight-induced microgravity as well. Thus, 
Figure 10. Cross platform comparison of hypergravity and vector-averaged gravity (vag)/flight-induced
microgravity-sensitive transcript clusters (TCs) from ground based facilities (GBFs) and suborbital
ballistic rocket experiments. (a) Venn diagram showing overlap of the hypergravity and vag-sensitive
TCs from GBF with the hypergravity and microgravity-sensitive TCs from suborbital ballistic rocket
experiments (yellow area). Numbers are differentially expressed TCs considering all TCs on the
Affymetrix GeneChip™ Human Transcriptome Array 2.0. The numbers of differentially expressed
annotated TCs are given in brackets. All 6 TCs in the overlap section are regulated in the same direction
in all gravity ond tions from both experimental platforms. (b) Bar chart showing fold c anges (FCs) of
the 6 TCs in all 4 relevant comp risons. FCs are ratios of the averaged expression valu s (linear) of a
TC from the compared experimental groups. All TCs are upregulated in the 4 comparisons.
2.5. Maximally, Minimally and Non-Controlled Cross Platform Comparisons
To assess the effects of strict filtering (strictly controlled) that have been used to avoid false
positive hits of differentially expressed TCs (Figure 11a), differential gene expression in vag and
flight-induced microgravity was additionally examined in minimally (Figure 11b) and non-controlled
comparisons (Figure 11c). While under maximum control conditions, 16 TCs differentially expressed
in flight-induced microgravity and vag could be identified, while under minimally and non-controlled
conditions, 271 and 431 TCs respectively emerged as being differentially expressed for both platforms.
This means that, even under non-controlled conditions, only 12% of the differentially regulated TCs
identified in flight-induced microgravity could be verified by the application of vag using a 2D
clinostat. On the other hand, 38% of the 1141 differentially expressed TCs identified in vag show gene
expression differences in flight-i duced microgravity as well. Thus, the clinostat experiments identified
roughly only one third of the transcripts that were actually differentially regulated in flight-induced
microgravity. We performed a similar analysis for hypergravity-sensitive transcripts and analyzed
maximally, minimally and non-controlled comparisons that are differentially expressed in hypergravity
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on both platforms (Figure 11d–f). Here, we identified, under maximum control conditions (Figure 11d)
45 TCs, and under non-controlled conditions (Figure 11f) 1520 TCs in the intersection of the two
platforms. This means that under non-controlled conditions, again 38% of the differentially regulated
TCs identified in hypergravity on a suborbital rocket could be verified by experiments performed with
a 9× g centrifuge. Conversely, from the 5778 differentially expressed TCs identified in hypergravity
of the 9× g centrifuge, only 26%, roughly one quarter, were also found to be differentially regulated
during the hypergravity phase of a suborbital ballistic rocket flight.
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hyperg avity-sensit ve T from ground based facilities (GBFs) experiments and suborbital
ballistic rocket flights. For the suborbital ballistic rocket experiments microgravity-sensitive and
hypergravity-sensitive TCs are identified by c ris f µg and TX hyp-g with the H/W 1× g
GC group. Differential expression is defined as p-value < 0.05; fold change −1.3 or ≥ 1.3. Numbers
represent differentially expressed TCs considering all TCs on the Affymetrix GeneChip™ Human
Transcriptome Array 2.0. The numbers of differentially expressed annotated TCs are given in brackets.
vag/flight-induced microgravity-sensitive TCs (left panel): Venn diagrams show the overlap (yellow
areas) of (a) GBF experiments controlled by exclusions of all transcripts that are differentially expressed
in the comparison 1× g control vs. BL, and suborbital ballistic rocket experiments controlled by
exclusion of the comparisons H/W 1× g GC vs. CC and 1× g IF vs. H/W 1× g GC, (b) GBF experiments
controlled by exclusion of all transcripts that are differentially expressed in the comparison 1× g control
vs. BL, and suborbital ballistic rocket experiments controlled by exclusion of the comparison 1× g IF vs
H/W 1× g GC, (c) non-controlled version of the microgravity-sensitive TCs. Hypergravity-sensitive
TCs (right panel): Venn diagrams show the overlap (yellow areas) of (d) GBF experiments controlled
by exclusion of all transcripts that are differentially expressed in the comparison 1× g control vs. BL,
and suborbital ballistic rocket experiments controlled by exclusion of the comparisons H/W 1× g GC
vs. CC and 1× g IF vs. H/W 1× g GC, € GBF experiments controlled by exclusions of all transcripts
that are differentially expressed in the comparison 1× g control vs. BL, and suborbital ballistic rocket
experiments controlled by exclusion of the comparison 1× g IF vs. H/W 1× g GC, (f) non-controlled
version of the hypergravity-sensitive TCs.
2.6. Development of Hypergravity-Sensitive TCs Over Time
Figure 12 summarizes the hypergravity results of the comparison of the two platforms, 9× g
centrifuge and suborbital rocket. During the hypergravity phase of the TEXUS-51 suborbital rocket
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flight, 104 TCs were identified to be upregulated and 242 TCs were downregulated, while 43049 TCs
showed no response. From the 104 upregulated TCs, we identified 29 TCs (28%) as also upregulated
in the 9× g centrifuge experiment. One TC was downregulated, 60 TCs showed no response and
14 were excluded (“eliminated”) by control comparisons. In case of the 242 downregulated TCs of
TEXUS-51, four TCs (2%) were also downregulated in the 9× g centrifuge experiment, eight TCs were
upregulated, 198 TCs displayed no response, and 32 were eliminated in control comparisons. From the
43049 non-responsive TCs of the hypergravity phase of the TEXUS-51 mission, 40909 (95%) were also
non-responsive in the 9× g centrifuge experiment. However, a large number of the non-responsive TCs
identified in the TEXUS-51 platform were found to be differentially expressed in the 9× g centrifuge
experiment (1011 upregulated and 448 downregulated).
Relative to the total number of TCs examined (43395), 33 TCs (< 0.1%) showed a continuous
response to hypergravity, 267 TCs (0.6%) an adaptation, 1459 TCs (3.4%) a late response and 40909
TCs (94.3%) no response at all. Meanwhile, 727 TCs (1.7%) were eliminated in control comparisons
(Figure 12).
2.7. Comparison of Gene Regulation in Flight-Induced Microgravity and Vector-Averaged Gravity
Figure 13 summarizes the results of the comparisons of the two platforms regarding vag and
flight-induced microgravity. During the microgravity phase of the TEXUS-51 suborbital rocket flight,
72 TCs were identified to be upregulated and 324 TCs were downregulated, while 42999 TCs showed
no response. From the 72 upregulated TCs, we identified eight TCs (11%) as also upregulated in the
2D clinostat experiment. No TC was downregulated, 61 TCs showed no response, and three TCs were
eliminated by control comparisons. In case of the 324 downregulated TCs of TEXUS-51, one TC (< 1%)
was also downregulated in the 2D clinostat experiment, two TCs were upregulated, 295 TCs displayed
no response, and 26 TCs were eliminated in control comparisons. From the 42999 non-responsive
TCs of the TEXUS-51 mission, 42086 (98%) were also non-responsive in the 2D clinostat experiment.
However, a number of the non-responsive TCs identified for the TEXUS-51 platform were found to be
differentially expressed in the 2D clinostat experiment (171 upregulated and 44 downregulated).
Relative to the total number of TCs examined (43395), nine TCs (< 0.1%) showed the same
response in flight-induced and vag, 358 TCs (0.8%) showed no or reverse response, 215 TCs (0.5%)
were sensitive only to vag, and 42086 TCs (97.0%) displayed no response at all. Further, 727 TCs (1.7%)
were eliminated in control comparisons (Figure 13).
2.8. Cross Platform and Altered Gravity Condition Overlap Analysis of TC Regulation in Vector-Averaged
Gravity, Flight-Induced Microgravity, and Hypergravity in GBF and TEXUS-51
Table 8 displays a cross platform comparison. In the left column, the number of upregulated,
downregulated and non-responsive TCs of the primary comparison are shown. In the right part of the
table, the distribution of these TCs within the remaining altered gravity comparisons is listed. In case of
the primary comparison 2D clinostat versus 1× g control, most of the differentially regulated TCs (94.5%
and 68.9%, respectively) can also be found in the comparison 9× g centrifuge versus 1× g control. For
the primary comparison TX µg versus 1× g IF representing differential gene expression in flight-induced
microgravity, only 11.6% of the upregulated and 1% of the downregulated TCs can be confirmed in
vag (2D clinostat vs. 1× g control). Interestingly, the major part of the TCs can also be found in the
hypergravity comparison 9× g centrifuge vs. 1× g control (34.8%) and TX hyp-g vs. 1× g IF (73.91% of
the upregulated TCs and 21.81% of the downregulated TCs). Regarding the primary comparison 9× g
centrifuge versus 1× g control, 16.3% of the upregulated and 6.8% of the downregulated TCs could be
confirmed in the comparison 2D clinostat versus 1× g control. In case of the primary comparison TX
hyp-g vs. 1× g IF, about one third (32.2%) of the upregulated TCs could be confirmed to be upregulated
in the comparison 9× g centrifuge versus 1× g control. Additionally, 56.7% of the upregulated and 31.0%
of the downregulated hypergravity-sensitive TCs could be verified in flight-induced microgravity,
indicating that many of the identified TCs are hypergravity and microgravity “double sensitive”.
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Figure 12. Development of hypergravity-sensitive transcript clusters (TCs) over time. Jurkat T cells
were exposed to 75 s of hypergravity (max. 12.6× g) during the suborbital ballistic rocket flight of
TEXUS-51 and to 300 s of hypergravity (9× g) in a centrifuge. TCs significantly up or downregulated
upon hypergravity were identified by microarray-based gene expression analysis. Numbers represent
differentially expressed TCs considering all TCs on the Affymetrix GeneChip™ Human Transcriptome
Array 2.0. The numbers of annotated TCs are given in brackets. The TCs are grouped according to
their response to 75 s of hypergravity (upper left column) and are further subdivided according to their
response to 300 s of hypergravity (upper right column). Finally, the transcripts can be classified as
either showing a continuous response over 75 s and 300 s hypergravity, undergoing adaption (response
after 75 s but opposite or no response after 300 s), being late responsive (responsive only after 300 s),
or being non-responsive to hypergravity (lower part). The vast majority of TCs did not respond to
hypergravity at all. Even more TCs turned out to be adaptive (267 and 89 TCs, respectively) rather than
having a continuous response (33 and 22 TCs, respectively) to hypergravity exposure.
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Figure 13. Comparison of gene regulation in flight-induced microgravity and vector-averaged gravity 
(vag). Jurkat T cells were exposed to 300 s of microgravity during the suborbital ballistic rocket flight 
of TEXUS-51 and to 300 s of vag in a 2D clinostat. Significantly up or downregulated transcript clusters 
(TCs) were identified by microarray-based gene expression analysis. Numbers represent 
differentially expressed TCs considering all TCs on the Affymetrix GeneChip™ Human 
Transcriptome Array 2.0. The numbers of annotated TCs are given in brackets. The TCs are grouped 
according to their response to flight-induced microgravity (upper left column) and are further 
subdivided according to their response to vag (upper right column). Finally, the transcripts can be 
classified as showing either the same response vag and flight-induced microgravity, no or reverse 
response, response to vag, or not responsive at all. The vast majority of TCs did not respond to neither 
type of microgravity. Even more TCs were not regulated in the same way in flight-induced 
microgravity as in vag, rather than showing the same response. 
Figure 13. Comparison of gene regulation in flight-induced microgravity and vector-averaged gravity
(vag). Jurkat T cells were exposed to 300 s of microgravity during the suborbital ballistic rocket flight of
TEXUS-51 and to 300 s of vag in a 2D clinostat. Significantly up or downregulated transcript clusters
(TCs) were identified by microarray-based gene expression analysis. Numbers represent differentially
expressed TCs considering all TCs on the Affymetrix GeneChip™ Human Transcriptome Array 2.0.
The numbers of annotated TCs are given in brackets. The TCs are grouped according to their response
to flight-induced microgravity (upper left column) and are further subdivided according to their
response to vag (upper right column). Finally, the transcripts can be classified as showing either the
same response vag and flight-induced microgravity, no or reverse response, response to vag, or not
responsive at all. The vast majority of TCs did not respond to neither type of microgravity. Even more
TCs were not regulated in the same way in flight-induced microgravity as in vag, rather than showing
the same response.
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Table 8. Cross platform and altered gravity condition overlap analysis of transcript cluster (TC) regulation in vector-averaged gravity (vag), flight-induced microgravity,
and hypergravity in GBF and TEXUS-51 (the four comparisons 2D clinostat vs. 1× g control, TX µg vs. 1× g IF, 9× g centrifuge vs. 1× g control, and TX hyp-g vs. 1× g
IF are included). A two-step classification of differentially expressed TCs is shown. TCs are first grouped according to a primary comparison shown on the left-hand
side (2D clinostat vs. 1× g control upregulated, downregulated, non-responsive). The right-hand side of the table shows how the transcripts from these groups
























2D Clinostat vs. 1× g Control TX µg vs. 1× g IF 9× g Centrifuge vs. 1× g Control TX hyp-g vs. 1× g IF
All Annotated All Annotated All Annotated All Annotated
up-regulated 181 0.42% 127 0.61% up-regulated 8 4.4% 5 3.9% 171 94.5% 125 98.4% 8 4.4% 5 3.9%
down-regulated 2 1.1% 0 0.0% 0 0.0% 0 0.0% 1 0.6% 0 0.0%
non-responsive 171 94.5% 122 96.1% 10 5.5% 2 1.6% 172 95.0% 122 96.1%
down-regulated 45 0.11% 12 0.06% up-regulated 0 0.0% 0 0.0% 0 0.0% 0 0.0% 0 0.0% 0 0.0%
down-regulated 1 2.2% 0 0.0% 31 68.9% 7 58.3% 0 0.0% 0 0.0%
non-responsive 44 97.8% 12 100.0% 14 31.1% 5 41.7% 45 100.0% 12 100.0%
non-responsive 42442 99.47% 20748 99.33% up-regulated 61 0.1% 32 0.2% 877 2.1% 692 3.3% 82 0.2% 50 0.2%
down-regulated 295 0.7% 75 0.4% 422 1.0% 159 0.8% 209 0.5% 56 0.3%

















IF TX µg vs. 1× g IF 2D Clinostat vs. 1× g Control 9× g Centrifuge vs. 1× g Control TX hyp-g vs. 1× g IF
All Annotated All Annotated All Annotated All Annotated
up-regulated 69 0.16% 37 0.18% up-regulated 8 11.6% 5 13.5% 24 34.8% 16 43.2% 51 73.91% 30 81.1%
down-regulated 0 0.0% 0 0.0% 0 0.0% 0 0.0% 0 0.00% 0 0.0%
non-responsive 61 88.4% 32 86.5% 45 65.2% 21 56.8% 18 26.09% 7 18.9%
down-regulated 298 0.70% 75 0.36% up-regulated 2 0.7% 0 0.0% 3 1.0% 0 0.0% 0 0.00% 0 0.0%
down-regulated 1 0.3% 0 0.0% 7 2.3% 3 4.0% 65 21.81% 11 14.7%
non-responsive 295 99.0% 75 100.0% 288 96.6% 72 96.0% 233 78.19% 64 85.3%
non-responsive 42301 99.14% 20775 99.46% up-regulated 171 0.4% 122 0.6% 1021 2.4% 801 3.9% 39 0.09% 25 0.1%
down-regulated 44 0.1% 12 0.1% 446 1.1% 163 0.8% 145 0.34% 45 0.2%
non-responsive 42086 99.5% 20641 99.4% 40834 96.5% 19811 95.4% 42117 99.57% 20705 99.7%

























9× g Centrifuge vs. 1× g Control 2D Clinostat vs. 1× g Control TX hyp-g vs. 1× g IF TX µg vs. 1× g IF
All Annotated All Annotated All Annotated All Annotated
up-regulated 1048 2.46% 817 3.91% up-regulated 171 16.3% 125 15.3% 29 2.8% 22 2.7% 24 2.3% 16 2.0%
down-regulated 0 0.0% 0 0.0% 8 0.8% 5 0.6% 3 0.3% 0 0.0%
non-responsive 877 83.7% 692 84.7% 1011 96.5% 790 96.7% 1021 97.4% 801 98.0%
down-regulated 453 1.06% 166 0.79% up-regulated 0 0.0% 0 0.0% 1 0.2% 1 0.6% 0 0.0% 0 0.0%
down-regulated 31 6.8% 7 4.2% 4 0.9% 0 0.0% 7 1.5% 3 1.8%
non-responsive 422 93.2% 159 95.8% 448 98.9% 165 99.4% 446 98.5% 163 98.2%
non-responsive 41167 96.48% 19904 95.29% up-regulated 10 0.0% 2 0.0% 60 0.1% 32 0.2% 45 0.1% 21 0.1%
down-regulated 14 0.0% 5 0.0% 198 0.5% 51 0.3% 288 0.7% 72 0.4%




















TX hyp-g vs. 1× g IF 2D Clinostat vs. 1× g Control 9× g Centrifuge vs. 1× g Control TX µg vs. 1× g IF
All Annotated All Annotated All Annotated All Annotated
up-regulated 90 0.21% 55 0.26% up-regulated 8 8.9% 5 9.1% 29 32.2% 22 40.0% 51 56.7% 30 54.5%
down-regulated 0 0.0% 0 0.0% 1 1.1% 1 1.8% 0 0.0% 0 0.0%
non-responsive 82 91.1% 50 90.9% 60 66.7% 32 58.2% 39 43.3% 25 45.5%
down-regulated 210 0.49% 56 0.27% up-regulated 1 0.5% 0 0.0% 8 3.8% 5 8.9% 0 0.0% 0 0.0%
down-regulated 0 0.0% 0 0.0% 4 1.9% 0 0.0% 65 31.0% 11 19.6%
non-responsive 209 99.5% 56 100.0% 198 94.3% 51 91.1% 145 69.0% 45 80.4%
non-responsive 42368 99.30% 20776 99.47% up-regulated 172 0.4% 122 0.6% 1011 2.4% 790 3.8% 18 0.0% 7 0.0%
down-regulated 45 0.1% 12 0.1% 448 1.1% 165 0.8% 233 0.5% 64 0.3%
non-responsive 42151 99.5% 20642 99.4% 40909 96.6% 19821 95.4% 42117 99.4% 20705 99.7%
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3. Discussion
We analyzed the influence of altered gravity on the gene expression response of non-activated
Jurkat T lymphocytes using the GBFs fast rotating 2D clinostat and a 9× g centrifuge. Both platforms
hold the same type of pipettes containing cell samples. During 5 min of vag in the clinostat, we found
768 significantly upregulated and 373 significantly downregulated TCs compared to 1× g controls,
while 5 min of 9× g hypergravity induced 3046 significantly upregulated and 2732 significantly
downregulated TCs. The baseline control (1× g control vs. BL) revealed 2125 significantly upregulated
and 496 significantly downregulated TCs, reflecting the influence of filling of the cell suspension into
the pipettes and releasing the cell suspension from the pipettes (Table 2). Eliminating those significantly
differentially expressed TCs due to pipette usage yielded 644 upregulated and 227 downregulated
TCs after 5 min of vag, and 2753 upregulated and 1843 downregulated TCs after 5 min of 9× g
hypergravity (Table 3). The significantly differential gene expression response ranged between −4.00
and +4.28-fold changes.
We also analyzed the gene expression in non-activated human Jurkat T lymphocytes in microgravity
and hypergravity during the TEXUS-51 sounding rocket campaign. The suborbital ballistic flight
provided 75 s of hypergravity during the rocket launch followed by 5 min of flight-induced microgravity.
Exposure of Jurkat cells to 5 min of hypergravity in the 9× g GBF centrifuge and to hypergravity
of the rocket flight resulted in 42 differentially regulated TCs respectively, 28 annotated TCs being
significantly differentially expressed using both research platforms (Figures 8 and 12, Table 6). A
functional gene ontology analysis of the associated genes revealed an association of the genes to
transport, cytosol, nucleotide binding, Poly(a) RNA binding, nuclear speck, RNA binding, intracellular
membrane-bounded organelles, and regulation of alternative mRNA splicing via the spliceosome
(Table 7).
When we compared the vag -sensitive TCs of the GBF experiment with the flight-induced
microgravity-sensitive TCs of the suborbital rocket flight, 11 TCs respectively (five annotated TCs) were
significantly altered using both research platforms (Figures 9 and 13). Among these annotated five
TCs are: (1) the G3BP1 (G3BP stress granule assembly factor 1) enzyme, that unwinds DNA and RNA
duplexes in an ATP-dependent manner, (2) KPNB1 (karyopherin subunit beta 1) which is involved in
nucleocytoplasmic transport of e.g. ribosomal proteins or H1, H2A, H2B, H3, and H4 histones, (3)
NUDT3 (nudix hydrolase 3) involved in nucleoside phosphate metabolic pathways and negatively
regulating the ERK1/2 pathway, (4) POMK (protein-O-mannose kinase), which is involved in forming
transmembrane linkages between the extracellular matrix and the exoskeleton, and (5) SFT2D2 which
seems to participate in the fusion of retrogradely transported endosomes with the Golgi complex
(Tables 6 and 9). A functional gene ontology analysis of these TCs showed no significant association to
cellular functions or processes.
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Table 9. Gene and protein description of hypergravity and microgravity-sensitive transcript clusters differentially expressed in GBFs and sounding rocket flight.
Adapted from NCBI and UniProt.
Condition Gene ID ENSEMBL Gene Name UniProt Protein Name Shortened Description (UniProt)
Hyp-g G3BP1 G3BP stress granule assemblyfactor 1
Ras GTPase-activating
protein-binding protein 1
ATP- and magnesium-dependent helicase that plays an essential
role in innate immunity.
Hyp-g & µg KPNB1 karyopherin subunit beta 1 Importin subunitbeta-1
Functions in nuclear protein import, either in association with an
adapter protein, like an importin-alpha subunit, which binds to
nuclear localization signals (NLS) in cargo substrates, or by acting
as autonomous nuclear transport receptor.




Cleaves a beta-phosphate from the diphosphate groups in
PP-InsP5 (diphosphoinositol pentakisphosphate) and [PP]2-InsP4
(bisdiphosphoinositol tetrakisphosphate), suggesting that it may
play a role in signal transduction.
Hyp-g POMK protein O-mannose kinase protein O-mannose kinase
Generates phosphorylated O-mannosyl trisaccharide which is a
carbohydrate structure present in alpha-dystroglycan (DAG1),
which is required for binding laminin G-like domain-containing
extracellular proteins with high affinity.
Hyp-g SFT2D2 SFT2 domain containing 2 vesicle transport protein SFT2B May be involved in fusion of retrograde transport vesiclesderived from an endocytic compartment with the Golgi complex.
µg CBFB core-binding factor subunit beta core-binding factor subunit beta
Forms the heterodimeric complex core-binding factor (CBF) with
RUNX family proteins. RUNX members modulate the
transcription of their target genes, within their regulatory regions
via their runt domain, while CBFB is a non-DNA-binding
regulatory subunit that allosterically enhances the
sequence-specific DNA-binding capacity of RUNX.
µg SAMD9 sterile alpha motif domaincontaining 9
sterile alpha motif
domain-containing protein 9
May play a role in the inflammatory response to tissue injury and
the control of extra-osseous calcification, acting as a downstream
target of TNF-alpha signaling.
µg SRSF6 serine and arginine rich splicingfactor 6
serine/arginine-rich splicing
factor 6
Plays a role in constitutive splicing and modulates the selection of
alternative splice sites.
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The analysis of hypergravity and microgravity double-sensitive TCs in both platforms revealed
four annotated TCs associated with 4 genes: (1) G3BP1, (2) KPNB1, (3) NUDT3, (4) SFT2D2, all of
which have already been identified as vag/flight-induced microgravity-sensitive (Table 6).
Interestingly, the direct comparison of hypergravity and vag/flight-induced microgravity-sensitive
TCs between the platforms showed that the GBF experiments revealed about five times as many
hypergravity as vag-sensitive TCs. Furthermore, the 2D clinostat and 9× g centrifuge experiments
showed more up than downregulated TCs. We could not observe this effect in the data of
the TEXUS-51 mission. Here, no major differences between the number of hypergravity and
flight-induced microgravity-sensitive TCs were observed, and the differentially expressed TCs were
rather downregulated instead of upregulated (Figure 5).
Our results indicate that less than 1% of all examined transcripts show the same response in vag and
flight-induced microgravity. Even when only considering the 396 transcripts differentially expressed in
flight-induced microgravity, less than 12% show the same response in flight-induced microgravity and
vag. Based on these surprising results, we have reinvestigated the forces prevailing in a 2D clinostat,
commonly accepted to be classified as simulated microgravity. To simplify the calculations for our
system, we assumed that human Jurkat T cells in suspension behave like small particles.
The study of particle behaviors in flows is a fundamental problem in fluid dynamics and a
number of theoretical, computational, and experimental studies have investigated the trajectory of
spherical particles in purely rotational flows. Given the dimensions of the cells and clinostat, only
studies pertaining to low Reynolds number flows are relevant in this context. Lin and colleagues [48]
theoretically analyzed the trajectories of particles in rotational flow at small but finite Reynolds
numbers and demonstrated that buoyant particles converge to a stable equilibrium position located
under the rotational plane in accordance with experimental observations [49]. In contrast, particles
denser than the surrounding fluid do not have a stable equilibrium point and ultimately follow a
divergent trajectory, spiraling outward. Brought back to the dimensions of the problem at hand, the
spiraling motion of the particle over 5 min would not markedly deviate from the circular motion of the
surrounding media.
In shear and rotational flows, fluid inertia further causes the particle to spin. For small Taylor
numbers (Ta = r
2ω
µ/ρ ) (with r: radius,ω: angular velocity, µ: viscosity, p: density) the angular velocity of
the particle (Ωp) relates to that of the fluid as follows:
Ωp
ω






In our application, Ta is in the order of 10−5. The particle angular velocity can thus be considered
equal to that of the clinostat.
Summarizing the above, Figure 14 illustrates the general motion of a spherical particle matching
the characteristic dimension and density of human Jurkat T cells over one revolution of clinorotation.
As particle and clinostat have the same rotation rate, the gravitational force and associated hydrostatic
pressure gradients follow a cyclic pattern in the particle reference frame, for the gravitational force
with a null average, and for the pressure with an average of 15 Pa over one revolution per second. In
contrast, the centrifugal force and resultant hydrostatic pressure gradients, as well as shear stresses
associated with the outward radial displacement of the particle, have a constant direction in the
particle reference frame (Figure 14d). However, as stated earlier, it should be kept in mind that the
maximal centrifugal force in the clinostat is 0.006× g and therefore very small compared to the normal
unidirectional gravitational force.
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the investigated Jurkat T cells over one clinorotation. (a) The fluid flow velocity differs depending on 
the location in the rotating vessel. Cells in suspension follow the fluid flow in the system. The circle 
represents a cell with the black dot labelling a fixed location on the cell surface to help visualize the 
cell orientation. (b) Evolution of the average pressure on the cell over time. The mean pressure over 
1 s is 14.7 Pa. However, at the bottom the pressure is 29.4 Pa higher compared to the top of the pipette. 
Gravitational (blue arrow) and centrifugal forces (red arrow) experienced at selected locations along 
the cell trajectory in the laboratory reference frame (c) and in the rotating reference frame (d). In the 
rotating reference frame, the radial component of the centrifugal force is constant while the radial 
component of the gravitational force is periodic. Note that for visibility on the figure, the particle 
diameter is scaled up 10 times relative to that of the clinostat and the centrifugal force is scaled up 100 
times compared to gravity. Black arrow: direction of rotation. 
In contrast to real microgravity environments, cells in a clinostat still experience gravitational 
forces albeit with a constantly changing direction (Figure 14c,d). The Jurkat T cells in our experiment 
are constantly exposed to oscillating forces with maximum changes of 29.4 Pa, 2.3 mPa, and 17.5 × 
10−12 N for pressure, shear stress, and gravitational force, respectively (Figure 14). For a rotation speed 
Figure 14. Illustration of the trajectory of a spherical particle with the same diameter and density as
the investigated Jurkat T cells over one clinorotation. (a) The fluid flow velocity differs depending
on the location in the rotating vessel. Cells in suspension follow the fluid flow in the system. The
circle represents a cell with the black dot labelling a fixed location on the cell surface to help visualize
the cell orientation. (b) Evolution of the average pressure on the cell over time. The mean pressure
over 1 s is 14.7 Pa. However, at the bottom the pressure is 29.4 Pa higher compared to the top of the
pipette. Gravitational (blue arrow) and centrifugal forces (red arrow) experienced at selected locations
along the cell trajectory in the laboratory reference frame (c) and in the rotating reference frame (d).
In the rotating reference frame, the radial component of the centrifugal force is constant while the
radial component of the gravitational force is periodic. Note that for visibility on the figure, the particle
diameter is scaled up 10 times relative to that of the clinostat and the centrifugal force is scaled up 100
times compared to gravity. Black arrow: direction of rotation.
In contrast to real microgravity environments, cells in a clinostat still experience gravitational
forces albeit with a constantly changing direction (Figure 14c,d). The Jurkat T cells in our experiment
are constantly exposed to oscillating forces with maximum changes of 29.4 Pa, 2.3 mPa, and 17.5 ×
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10−12 N for pressure, shear stress, and gravitational force, respectively (Figure 14). For a rotation
speed of 60 rpm, the direction of gravitational forces integrated over 1 s (corresponding to one
revolution of the clinostat) are averaged. According to the clinostat theory [20,30], the biological
effect of gravitational forces is canceled, if the initial trigger mechanism requires at least one second
of stimulation, corresponding to one full 360-degree rotation in a 2D clinostat rotating with 60 rpm.
Because the transcriptome response during the microgravity phase provided by a suborbital ballistic
rocket flight was not detectable in vag provided by a 2D clinostat, it is unlikely that the initial trigger
of gravitational force transduction into the chromatin lasts longer than one second.
Our experiments are limited by the inherent limitation of ballistic trajectories, the launch and
hypergravity phase, which is preceding always the microgravity phase. Although we applied four types
of control experiments (Figure 1), not controlled artifacts induced by the preceding force conditions
cannot be fully excluded. In our experiments, only less than 1% of the transcriptome changes in
flight-induced microgravity could be reproduced by clinorotation. Our data suggest that the initial
trigger and perception mechanisms of gene expression changes in microgravity is faster than one
second. Indeed, mechanical force transduction into the chromatin occurs within milliseconds [50],
allowing the nuclear structure to respond directly without biochemical signaling [51,52]. In previous
studies which have investigated the oxidative burst reaction in mammalian macrophage cells in
microgravity, rapid adaption to a microgravity environment was detected in microgravity on board of
the ISS [10], but not in the vag of clinorotation experiments [12,53,54].
If 99% of such pivotal events cannot be simulated by analogous clinostat experiments, the general
assumption that 2D clinostats provide a valid simulation of microgravity and can be recommended for
most biological organisms [20] should be revised. If in addition the primary trigger of gravity-induced
gene expression response [10,46] is less than one second, the fundamental question of suitability
of the clinostat system for the investigation of mammalian cells arises. We therefore recommend
that sufficient validation experiments should be carried out before starting experiments with vag as
simulation for real microgravity.
Additionally, we discovered extensive gene expression differences caused by simple handling of
the cell suspension in control experiments, which underlines the need for rigorous standardization
regarding mechanical forces occurring during cell culture experiments in general.
4. Materials and Methods
Material and methods have been described in our previous studies [13,14].
4.1. Cell Culture
The standard cell culture conditions for the human cell line Jurkat T cells (ATCC Clone E6-1,
TIB-152, Manassas, VA, USA) were described previously [3,4]. Briefly, cells were kept in a standard
cell culture incubator (5% CO2, 100% humidity, 37 ◦C) and were cultured in RPMI1640 medium
(Biochrom/Merck Millipore, Darmstadt, Germany), supplemented with 10% fetal bovine serum
(FBS Superior; Biochrom/Merck Millipore, Darmstadt, Germany), 2 mM glutamine (low endotoxin;
Biochrom, Darmstadt, Germany), and 100 U/mL penicillin, as well as 100 µg/mL streptomycin
(Biochrom, Darmstadt, Germany). The Jurkat cells were subcultured every other day and reseeded at a
density of 0.2 × 106 cells/mL. A trypan blue assay was used for the quantification and assessment of
cell viability (between 97% and 100%). The measured population doubling time ranged between 24
and 28 h.
4.2. TEXUS-51 Suborbital Ballistic Rocket Experiment
TEXUS-51 was a German Center for Aerospace (DLR) funded suborbital ballistic rocket mission.
The vehicle assembly comprised the experiment payload on top of a two-stage VSB-30 rocket motor.
The rocket launch was performed on 23 April 2015 at 09:35 from the ESRANGE Space Center in Sweden.
Excerpt of the flight profile: (i) altitude: 258 km, (ii) total microgravity time: 369 s (10−5× g), (iii) 8.1× g
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first stage peak thrust acceleration, (iv) 5.1× g mean thrust acceleration, (v) first stage burnout at 12.1 s,
(vi) engine separation at 13.4 s, (vii) 12.6× g second stage peak thrust acceleration, (viii) 6.7× g mean
thrust acceleration, (ix) burnout at 43.2 s, (x) yo-yo despin at 56.0 s, and (xi) motor separation at 59.0 s.
4.3. TEXUS-51 Mission Procedures
The TEXUS-51 mission procedures have been previously described [13,14,55,56]. Briefly, three
syringes were assembled into one unit. One syringe was filled with human Jurkat T cells (25 million
cells), a second syringe contained cell culture medium, and a third syringe contained TRIzol LS (Life
Technologies, Darmstadt, Germany) as lysis solution. The syringes were closed by small plugs to
prevent the premature mixture of the liquids. A T piece connected the three syringes of one unit
which was integrated into a temperature controlled and vacuum-resistant container (Figure 1(b1)). The
activation of the syringes was controlled automatically during the experiment at pre-set times using a
pneumatic system. Seven hours before launch, the experiment preparation started, and integration
of the experimental units took place 1:15 h to 0:45 h before launch via a late access port. During the
whole experiment and until lysis, the samples were temperature controlled at 36.5 ◦C ± 0.5 ◦C. The
disassembly and purification of samples were performed immediately after landing and recovery of
the payload. Total RNA was kept at −80 ◦C until processing for the microarray analysis.
4.4. Experimental Preparation Procedures for TEXUS-51 Experiments
Human Jurkat T cell culture was performed as previously described [13,14,55,56] in the ESRANGE
Space Center laboratory facilities. Briefly, sterile plastic syringes were filled with 0.5 mL Jurkat cells (25
million cells). Additionally, a second syringe was loaded with 0.3 mL cell culture medium, and 1 mL of
TRIzol LS (Life Technologies, Darmstadt, Germany) was filled in a third syringe. These three syringes
were assembled into one experimental unit with a sterile plastic T block including a connecting tubing
system. The experiment units were kept at 36.5 ◦C ± 0.5 ◦C until either integration into the flight
module or execution of ground controls. The experiment sequence was as follows: injection of (i)
0.3 mL cell culture medium, (ii) 1 mL TRIzol LS into the syringe containing the cells according to
pre-defined time points (Figure 2). In total, 39 samples were processed during the TEXUS-51 mission:
7 × 1× g ground cell culture controls (CC), 7 × H/W 1× g GC, 9 × 1× g IF, 7 × BL-TX hyp-g and 9 × µg.
4.5. Ground Based Facilities (GBFs) Experiments
Ground based simulation of microgravity is a common technique to pre-test and prepare spaceflight
experiments. In our experiments, 2D clinorotation (DLR pipette clinostat, Institute for Aerospace
Medicine, Gravitational Biology Group, Cologne, Germany) and centrifugation (pipette centrifuge, KEK
GmbH, Bad Schmiedeberg, Germany) were used for vag and hypergravity experiments, respectively.
For vag and centrifugation experiments, human Jurkat T cells from the same cell pool were used for
both experiment conditions. Then, 0.8 mL of cell suspension (25 million cells) was filled in a 1 mL
pipette (Becton Dickinson/Falcon, Basel, Switzerland) corresponding to the total amount of cells per
sample in the TEXUS-51 experiment. One end or both ends of the pipettes were sealed by rubber plugs
depending on whether they were used for clinorotation or centrifugation. Pipettes containing Jurkat
cells were then either placed in the 2D clinostat rotating with a speed of 60 rpm or in the centrifuge
set to 9× g at 37 ◦C for 300 s (Figure 1). The centrifugation force of 9× g was chosen to simulate
the acceleration of the TEXUS-51 suborbital ballistic rocket which lies in the range between 5.1× g
(first stage mean thrust acceleration) and 12.6× g (second stage peak thrust acceleration). For control
experiments, pipettes filled with Jurkat cells were placed on the base plate of the clinostat. These
1× g hardware controls were exposed to all non-clinorotation hardware effects including instrument
vibration for 300 s. A fourth sample group representing a pre-experiment baseline including potential
shear forces acting on the cells by aspiration and draining out of the pipette was performed to monitor
the effects of the filling procedure. After the respective incubation times, cell samples were mixed with
1 mL TRIzol LS (Life Technologies, Darmstadt, Germany) and homogenized with a needle (0.8 × 80
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mm; B Braun Melsungen, Melsungen, Germany) and a syringe. Total RNA was purified as described in
the following Section 4.6. Per sample group, 6 samples were analyzed with an Affymetrix GeneChip™
Human Transcriptome Array 2.0.
4.6. RNA Purification
A detailed protocol has been published previously [13,14,55,56]. In summary, the total sample
volume of 1.8 mL was sheared three times by passing through a 20 G needle (B. Braun Melsungen,
Melsungen, Germany). Subsequently, 0.2 mL chloroform (Sigma-Aldrich, Buchs, Switzerland) was
added, the sample was mixed and centrifuged. The upper phase was removed and mixed with 4 mL
RLT buffer (Qiagen, Hilden, Germany) and 3 mL ethanol, and processed using the RNeasy Midi Kit
(Qiagen, Hilden, Germany). Purified RNA was transported and stored at −80 ◦C.
4.7. RNA Sample Processing and Microarray Data Analysis
A detailed description of RNA sample processing and microarray data analysis can be found in
previous publications [13,14,55,56]. Briefly, the Affymetrix GeneChip™ Human Transcriptome Array
2.0 (Affymetrix United Kingdom Ltd., High Wycombe, UK) was used (44,699 protein coding and
22,829 non-protein coding genes). RNA samples with 260/280 nm ratios between 1.97 and 2.04 and
RNA integrity numbers > 8.2 were further processed. Fragmented and biotinylated DNA targets
were produced from 100 ng of total RNA following the standard Affymetrix GeneChip™ WT PLUS
Reagent Kit (Affymetrix United Kingdom Ltd., High Wycombe, UK) protocol. The DNA targets
were then hybridized (17 h, 45 ◦C) on Affymetrix GeneChip™ Human Transcriptome Arrays 2.0.
Washing and staining of the chips was performed in the Affymetrix Fluidics Station 450 (Affymetrix
United Kingdom Ltd., High Wycombe, UK) according to the standard Affymetrix GeneChip™ Wash,
Stain and Scan Kit protocol (Affymetrix United Kingdom Ltd., High Wycombe, UK), and scanned
with the Affymetrix 3000 7 G scanner (Affymetrix United Kingdom Ltd., High Wycombe, UK). The
Affymetrix Expression Console™ Software (Affymetrix United Kingdom Ltd., High Wycombe, UK)
and Transcriptome Analysis Console™ Software (Affymetrix United Kingdom Ltd., High Wycombe,
UK) was applied for data analysis. We used the robust multi-array average (RMA) algorithm combined
with a quantile normalization of the microarray data [57] where the background noise is subtracted
in order to avoid false positive results based on a low signal and high background. Subsequently,
a one-way analysis of variance (ANOVA) was employed to determine gene expression differences.
The values of two experiment groups were compared and fold changes ≥1.3 or ≤−1.3 with a p-value
(one-way ANOVA) of <0.05 were considered to represent a significantly differential gene expression.
The large number and homogeneity of the applied samples resulted in a low variance within the
sample groups and a high sensitivity of the applied method.
4.8. Applied Control Strategy for Revealing Microgravity and Hypergravity Sensitivity
To exclude that fold changes measured in the primary microgravity and hypergravity comparisons
were due to gravitational or other conditions preceding the respective phase, controls were applied:
Intersections were built between the primary comparison and the comparison that represents the
previous phase. Transcripts that were shown to be differentially expressed already in the preceding
phase were excluded from the pool of microgravity and hypergravity-sensitive Transcripts (see Figures
3a and 4a).
4.9. Intra-Platform and Inter-Platform Comparisons
To elucidate if transcripts were either only vag respectively flight-induced microgravity-sensitive,
hypergravity-sensitive, or sensitive to both conditions within one experimental platform
(intra-platform), intersections between the pools of vag respectively flight-induced microgravity
and hypergravity-sensitive transcripts were made. Furthermore, we analyzed if transcripts responded
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to vag respectively flight-induced microgravity or hypergravity in both experimental platforms by
inter-platform intersections.
4.10. Functional Annotation Analysis
Compilation of a functional annotation chart was performed with the Functional Annotation
Tool DAVID (DAVID Bioinformatics Resources 6.8, NIAID/NIH, https://david.ncifcrf.gov/summary.
jsp). As background lists “Homo sapiens” was used, and for compiling the functional
annotation chart the GENE-Ontology terms “GOTERM_BP_DIRECT”, “GOTERM_CC_DIRECT”, and
“GOTERM_MF_DIRECT" were applied.
4.11. Investigation of Forces Present in a Clinostat
As GBFs fundamentally differ from real microgravity, an analysis of the forces applied on the cells
in the vector-averaged gravity environment is warranted. Within the clinostat, the culture medium
undergoes a solid body rotation and the cells in suspension are free to move within the medium. The
total force acting on the particle results from the contributions of buoyancy and gravity, drag, lift,
inertia and added mass. Relevant parameters to consider thus include:
- The cell radius and density: r = 5.75 µm and ρc = 1.05− 1.12 g/mL [58]
- The medium density and viscosity: ρ f = 1.00 g/mL and µ = 1.09− 1.14 mPa·s [59]
- The clinostat radius and rotation rate: R = 1.5 mm and ω = 2pi rad/s.
The maximum centrifugal force in this setup is 0.006 g and the characteristic shear Reynolds
number, Res = r
2Ω
ν , is in the order of 10
−4.
4.12. Data Availability
The data sets analyzed for this study are available in the GEO (Gene Expression Omnibus)
repository (www.ncbi.nlm.nih.gov/projects/geo), accession no. GSE101102.
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